Početna › Kolesterol › Kalifornija
Kliničke studije za Kolesterol u državi Kalifornija
6 studija za Kolesterol traži sudionike na lokacijama u državi Kalifornija.
Službeni tekst studije (engleski)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Pacific Oaks Medical Group, Beverly Hills
- Cardiovascular Institute of San Diego, Chula Vista
- John Muir Medical Center - Concord Campus, Concord
- i još 10
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Huntington Beach
- Research Site, Loma Linda
- Research Site, Lomita
- i još 2
U tijeku regrutacijaFaza 3
Od 18 do 130 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Clinical Trials Research, Lincoln
- Downtown L A Research Center Inc, Los Angeles
- Valley Clinical Trials, Northridge
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07610278Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 24. srp 2026. · NCT06597006A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Anaheim Clinical Trials, Anaheim
- Cenexel CNS, Los Alamitos
- Diablo Clinical Research - Flourish Research, Walnut Creek
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. srp 2026. · NCT07477704Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
U tijeku regrutacijaFaza 3
Od 6 do 11 godina · Oba spola · Ažurirano 15. svi 2026. · NCT06597019Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.